Research Article

Albumin-Bilirubin Grade as a Novel Predictor of Survival in Advanced Extrahepatic Cholangiocarcinoma

Table 1

Basic characteristics of the included patients.

VariablesOverallALBI grade
1-2 ()3 ()

Gender (male/female)71/3828/1943/190.289
Age68.9 ± 11.167.2 ± 11.870.1 ± 10.40.155
Age (≥70/<70 years)57/5223/2434/280.541
Location (HCCA/DCCA)70/3931/1639/230.742
CA19-9 (ng/ml)534.3 (0.6–2068)291.3 (0.6–2068)936.2 (0.6–1967)0.006
CEA (ng/ml)4.4 (0.9–310.4)4.0 (0.9–294.85.5 (0.9–310.4)0.432
ALT (U/l)149 (22–531)128 (24–375)202 (22–513)0.006
AST (U/l)158 (28–541)152 (28–541)159.5 (35–365)0.976
ALP (U/l)553 (39–2556)487 (39–2451)646.5 (202–2556)0.110
GGT (U/l)543 (4.1–2528)636 (69–2528)492 (4.1–1706)0.073
TBIL (μmol/l)249.7 (14.1–706.2)161.8 (14.1–325.4)306.9 (47.3–706.2)<0.001
DBIL (μmol/l)201.4 (5.0–649.0)146.9 (5.0–299.0)261.4 (23–649<0.001
ALB (g/l)34.2 (23.6–45.3)38.3 (33.1–45.3)31.9 (23.6–35.7)<0.001
CRP (mg/l)16.8 (0.6–205.6)11.7 (0.6–111.9)28.2 (1.9–205.6)<0.001
PLT (109/l)237 (54–533)240 (117–483)237 (54–533)0.869
PT (s)11.6 (9.3–16.5)10.9 (9.4–12.9)12.1 (9.3–16.5)<0.001
PT-INR1.02 (0.65–16.5)0.98 (0.65–12.6)1.07 (0.83–16.5)<0.001
CP score 5/7/8/9/101/46/50/10/21/43/2/0/10/3/48/10/1<0.001
Outcome (death/no)86/2330/1755/70.002

ALBI: albumin-bilirubin; HCCA: hilar cholangiocarcinoma; DCCA: distal cholangiocarcinoma; CA19-9: carbohydrate antigen 19-9; CEA: carcinoembryonic antigen; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; TBIL: total bilirubin; DBIL: direct bilirubin; CRP: C-reactive protein; PLT: platelet count; ALB: albumin; PT: prothrombin time; PT-INR: prothrombin time-international normalized ratio; CP: Child-Pugh.